Mursla Company
Novel integrated platform for the discovery and profiling of exosome phenotypes in diseases.
Technology:
AgeTech Companies
Industry:
Deep diagnostics
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2019-03-01
Employees Number:
1-10
Funding Status:
Seed
Total Funding:
$750,000.00
Estimated Revenue:
$1M to $10M
Last Funding Type:
Undisclosed
Register and Claim Ownership